Related Experiment Videos

Lyme disease: a growing threat to urban populations

A C Steere1

  • 1Division of Rheumatology/Immunology, Tufts University School of Medicine, New England Medical Center, Boston, MA 02111.

Insights

Lyme disease, a tick-borne illness caused by Borrelia burgdorferi, has spread across North America and Eurasia. Early diagnosis and treatment are key, though challenges remain in managing late-stage neurological symptoms and combating misdiagnosis.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Tick-Borne Illnesses

Background:

  • Lyme disease, or Lyme borreliosis, is caused by Borrelia burgdorferi spirochetes and transmitted by Ixodes ticks.
  • Geographic spread is linked to glacial moraines and favorable deer ecology, with significant case increases reported in the US.
  • The disease presents in stages, mimics other conditions, and poses diagnostic challenges, particularly in late neurological presentations.

Purpose of the Study:

  • To provide an overview of Lyme disease epidemiology, clinical presentation, and management.
  • To highlight diagnostic difficulties and the issue of misdiagnosis with conditions like chronic fatigue syndrome.
  • To discuss treatment strategies and limitations in vector control for tick-borne diseases.

Main Methods:

  • Review of reported Lyme disease cases from the Centers for Disease Control (CDC).
  • Analysis of geographic distribution and historical spread patterns.
  • Comparison of Lyme disease manifestations with other conditions and diagnostic challenges.

Main Results:

  • Over 40,000 cases reported in the US between 1982-1991, with enzootic cycles in 19 states.
  • Focal outbreaks have occurred in new areas, including near major East Coast cities.
  • Misdiagnosis is common due to overlapping symptoms and diagnostic test limitations, especially for "chronic Lyme disease."

Conclusions:

  • Lyme disease requires careful diagnosis, with late neurological symptoms posing the greatest challenge.
  • Standard oral antibiotics are effective for most manifestations, but intravenous therapy may be needed for neurological issues.
  • Personal protection remains the primary method for reducing infection risk due to difficulties in vector control.

Related Concept Videos